glycerylphosphorylcholine has been researched along with transforming growth factor beta in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breitbart, E; Feldman, B; Ishai, E; Mendel, I; Volkov, A; Yacov, N | 1 |
1 other study(ies) available for glycerylphosphorylcholine and transforming growth factor beta
| Article | Year |
|---|---|
Treatment with lecinoxoids attenuates focal and segmental glomerulosclerosis development in nephrectomized rats.
Topics: Animals; Blood Cells; Collagen; Disease Models, Animal; Fibronectins; Glomerulosclerosis, Focal Segmental; Glycerophosphates; Glycerylphosphorylcholine; Kidney; Macrophages; Male; Monocytes; Nephrectomy; Podocytes; Pyridinium Compounds; Random Allocation; Rats; Rats, Sprague-Dawley; Toll-Like Receptor 2; Toll-Like Receptor 4; Transforming Growth Factor beta | 2019 |